Catalyst advises the shareholders of Raphael Healthcare on its sale to Elysium Healthcare

Catalyst’s Healthcare team has advised the Shareholders of Raphael Healthcare, a provider of specialist mental health services, on its sale to Elysium Healthcare. The deal was the first acquisition by BC Partners-backed Elysium Healthcare, which was established following the merger between Partnerships in Care and Priory Group. Elysium specialises in acute mental illness, personality disorders, eating disorders, secure and rehabilitation care across the 22 sites that were acquired from the merged group.

Raphael was established in 2004. The company provides award winning low secure mental health services for women at its Farndon Unit in Nottinghamshire and has a site with planning permission for a Tier 4 CAMHS unit at Briars Hey in Lancashire. Catalyst, who had known the company for many years, were initially appointed in September 2016 to undertake a strategic options review for the Company as the business had received a number of unsolicited approaches. We worked closely with the company’s lawyers Browne Jacobson to stress test the business and ensure it was prepared for an intensive diligence process.  

The deal was completed in a swift timescale, with six weeks between the signing of Heads of Agreement and completion.

Claire Thomson, CEO of Raphael Healthcare, commented: “We are extremely proud of the award winning service that we provide to our patients and stakeholders. The business has found a good new owner in Elysium who have the same values as us, placing a strong emphasis on quality and the same client focused values. This is a tremendous opportunity and natural progression for Raphael and one that should benefit service users, commissioners and our staff. The significant efforts and quality of advice provided by Catalyst ensured that we concluded this deal swiftly and to the satisfaction of all parties”.

Catalyst’s Healthcare team, led by partner Justin Crowther, advised on the deal and their knowledge and expertise in the care sector was an important factor in the process. Justin commented:

“We are delighted to have worked closely with the Shareholders of Raphael to achieve a successful outcome. Raphael is a market leading brand and the transaction will enable Elysium to develop further their specialist services and allow them to expand their geographical presence.”

< Go back to results

‘Sustainability’, the key to today’s packaging market

If anyone was still unsure as to the direction the packaging industry is taking, the 2017 Packaging Innovations trade show left little doubt... 

Strong M&A outlook for mid-market pharma

The dynamics highlighted by this year’s Catalyst Pharma Fast 50 show that the sector is prime for further acquisitions and private equity investment... 

Why mid-market pharma is thriving

If there’s one thing that this year’s Pharma Fast 50 emphasises, it is that privately owned pharmaceutical firms in the UK are thriving... 

Optimism on post-Brexit renewables innovation

The sustainability challenges posed by the UK’s forthcoming exit of the EU were a central topic at this year's annual EIC Conference... 

Independent Vetcare – barking up the right tree

The vet market continues to attract plenty of interest. Independent Vetcare is currently being sold in what is rumoured to be a hotly contested auction... 

Catalyst advises LDC on the secondary buy-out of Addo Food Group

Catalyst has advised LDC and the management team on the secondary buy-out of Addo Food Group (Addo) the UK’s leading chilled savoury pastry producer, from Vision Capital.  

Catalyst hosts Q&A with West Midlands mayoral candidate Andy Street

Catalyst has hosted a Q&A with West Midland’s mayoral candidate Andy Street, at its Birmingham Office.  

Catalyst has advised the shareholders of UK Heating Group, including Encore Capital, on the sale to Irsap Group

Catalyst Corporate Finance has advised the shareholders of UK Heating Group, including Encore Capital, on the sale to Irsap Group. 

Catalyst advises the shareholders of Thompson & Morgan on the sale to BVG Group

Catalyst has advised the shareholders of Thompson & Morgan Group Holdings, including Primary Capital, on the sale to BVG Group 

Catalyst advises Phoenix Equity Partners on its investment in Global Freight Solutions

Catalyst has advised Phoenix Equity Partners on its investment in Global Freight Solutions (Holdings) Ltd (GFS) alongside the current management team, led by CEO Neil Cotty.